A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Diseases Interventions:   Drug: Cotadutide 100 micrograms;   Drug: Cotadutide 300 micrograms;   Drug: Cotadutide 600 micrograms;   Drug: Semaglutide;   Drug: Placebo Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials